Company



Bridge4Bio targets four strategic areas to boost life science business growth

Kensington, CA, United States, January 28, 2010 - Bridge4Bio, an international business consultancy group focused on promoting the growth of life sciences and biotechnology companies, is targeting four strategic areas to assist both startups and established companies plan and grow their businesses globally.  Bridge4Bio’s team of senior consultants addresses the following:

Channel Development
Bridge4Bio’s senior management team with its global coverage helps clients find the appropriate distributor, or choose appropriate partners for OEM mergers or licensing deals to expand their business.

Strategic Marketing
Bridge4Bio provides guidance on how to build and implement a global business plan including developing new and existing product line channel strategies. Advice covers implementing market promotions and communication programmes, agreement negotiation, as well as ensuring IP and profitability are solid to capitalize on future opportunities.

Global Sourcing
Bridge4Bio’s international experience simplifies identifying the best sources to manufacture product, reduce cost, negotiate contracts, or improve quality through long-term global partnerships to gain a competitive advantage.

Capital Investment
Bridge4Bio is well connected to Silicon Valley and global investment contacts to act as a bridge between the client and an appropriate investor or partnership company.

“Forming a partnership with Bridge4Bio allows life sciences and biotechnology companies, both large and small, to maximize their growth potential while working with tight budgets,” explained Hugh Douglas, Bridge4Bio’s president. “Start-ups, small to mid-sized companies or those organizations needing to develop and expand their business globally with limited resources can all benefit from our global team of experts that are highly skilled and experienced at driving and managing operations, marketing, sales and business development across the full spectrum of the life sciences sector”.

Bridge4Bio’s knowledge and expertise covers academic research, drug discovery, pharmaceuticals, biotechnology, proteomics and genomics, medical devices and diagnostics.

Douglas continued: “Bridge4Bio provides our clients the experience of a network of ten international life sciences and biotechnology consultants who have all experienced first-hand the start-up and growth challenges faced by life sciences and biotechnology businesses in global markets”. 

“We cover the world.  Clients benefit from our pool of experienced professionals immediately.”

“Retaining Bridge4Bio also helps a company minimize risk by automatically giving access to a team of ten business experts with specialist global knowledge to work on projects.  In this way an organization can benefit from growing the business for a fraction of the cost of hiring a single employee for a year and then finding out later that the hire strategy did not work out.  We call it simply the ‘Power of Ten’”.

“Another advantage of using Bridge4Bio’s team is that we recognize that companies may not have the funds for high-priced consultants. So much of our fee structure is charged as commissions based on the sales/results of a growing business. The client pays us based on the success of the implementation which means that the up-front cost and risk is further reduced for our clients.”

Bridge4Bio will be exhibiting on stand number A3-380 at Analytica 2010, March 23 -26, 2010 Munich, Germany.

Media Contact
Phoenix MarCom Ltd
Tel: + 44 (0) 1223 873318
Fax: + 44 (0) 1223 874173
Email: marketing@phoenixmarcom.co.uk

Bridge4Bio, LLC
32 Kerr Avenue, Kensington CA 94707, USA
Tel: +1 510 559 8599 - Email: press@bridge4bio.com Website: www.bridge4bio.com

 

Information for Editors

Bridge4Bio is a business consultancy group focused on promoting the growth of life science companies.
President, Hugh Douglas offers more than 20 years of experience in managing general operations, manufacturing, R&D, finance and administration, and marketing and business development. Douglas, who was formerly the managing director/president of Hoefer, Inc., a global electrophoresis company, as well as vice president of West Coast Operations for Amersham Biosciences, also has experience in acquisitions and raising capital for new ventures.

Headquartered in the San Francisco Bay Area, Bridge4Bio maintains satellite offices in Sweden, United Kingdom, Israel, Southeast Asia, and India.

Contact Us Today »

Download our Fact Sheet:

Bridge4Bio serves many sectors including:

  • Drug discovery
  • Academic research
  • Biotech
  • Medical devices
  • Diagnostics
  • Pharmaceuticals